Brief: Kdventures' Umecrine Cognition Gets Two USPTO Notices Of Allowance For Patent Applications
07/09/2026 08:18
BRIEF-Kdventures' Umecrine Cognition Gets Two USPTO Notices Of Allowance For Patent Applications Sept 7 (Reuters) - Kdventures AB KDV.ST:
KDVENTURES AB - KDVENTURES' PORTFOLIO COMPANY UMECRINE COGNITION RECEIVES TWO NOTICES OF ALLOWANCE IN U.S. FOR SECOND-GENERATION GAMSA COMPOUNDS
Source text: ID:nMFN21SV3C
Further company coverage: KDV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Kdventures AB
See all newsRefile: BRIEF-Umecrine Cognition Gets Notice Of Allowance In US
Brief: KDventures' Modus Therapeutics Pauses Enrollment In Phase 2A Study
Brief: KDventures' AnaCardio Raises €62.5 Million
Brief: Kdventures' Umecrine Cognition Gets Two USPTO Notices Of Allowance For Patent Applications
Brief: Kdventures' Modus Therapeutics Carries Out Directed Issue